Russian Northern Fleet completes drills in ArcticMilitary & Defense September 22, 18:01
OPEC and non-OPEC countries to continue talks on oil production cut dealBusiness & Economy September 22, 17:28
Russian pair figure skaters Kavaguti, Smirnov retire from sportSport September 22, 16:48
Record number of delegations register for St. Petersburg-hosted IPU AssemblyRussian Politics & Diplomacy September 22, 16:47
Astronauts to make quickest trip ever to ISS in DecemberScience & Space September 22, 16:27
Russian frigate Admiral Essen returns to Crimea after mission in MediterraneanMilitary & Defense September 22, 16:24
Experts believe Russia not ready for crypto assetsBusiness & Economy September 22, 16:09
Trump vows to put North Korean leader to testWorld September 22, 15:56
Russia's top diplomat presents UN chief with film about him made by TASSSociety & Culture September 22, 15:43
MOSCOW, June 3. /TASS/. India’s Glenmark Pharmaceuticals Ltd is exploring an opportunity of localizing ready pharmaceutical drugs production in Russia, general director of Glenmark’s division in Russia Glenmark Impex Elena Astakhova said.
"We have such ideas and we are considering such an opportunity in principle. However, no final decision has been made yet," Astakhova said. She did not clarify the timeline and basic parameters of projects.
The company has no local production in Russia for the time being. The annual turnover of Glenmark in Russia is estimated at 2 bln rubles ($37.5 mln). Glenmark owns 14 ready drugs and substances factories in four countries and six research centers.